Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1953 of 5804
-
Virtual volunteering boosts stroke recovery and job prospects
Symptom relief Recruiting nowThis project will investigate effects of a novel theory-driven 6-week virtual Personal Resource Building and Inclusive Volunteering Intervention (PVI) on young stroke survivors' work ability, self-efficacy and psychosocial outcomes. It is hypothesised that participants in the in…
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Magnetic fields join the fight against breast cancer in first safety trial
Disease control CompletedTo assess the safety and tolerability of combined PEMFs and anthracycline-based chemotherapy in subjects who are undergoing neoadjuvant chemotherapy for breast cancer treatment.
Phase: PHASE1 • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New hope for rare liver disease: drug trial targets bile duct damage
Disease control OngoingThis study will evaluate the effects of elafibranor (the study drug) in participants with Primary Sclerosing Cholangitis (PSC) during the double-blind period, an initial 96 week open-label extension (OLE) period, and an optional open-label extension long-term (OLE-LT) period beyo…
Phase: PHASE2 • Sponsor: Ipsen • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New pill shows promise in early breast cancer trial
Disease control OngoingThis clinical trial is evaluating a drug called AC699 in participants with estrogen receptor positive/human epidermal growth factor 2 negative (ER+/HER2-) locally advanced or metastatic breast cancer. The main goals of this study are to: * Identify the recommended dose of AC699 …
Phase: PHASE1 • Sponsor: Accutar Biotechnology Inc • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New hope for toddlers with chronic constipation?
Symptom relief CompletedFunctional constipation (FC) is a common healthcare problem in children of all ages, potentially due to genetic predisposition, inadequate fiber and fluid intake, and immobility. Currently, there are no pharmacological therapies approved for the treatment of FC. This study will a…
Phase: PHASE3 • Sponsor: AbbVie • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Breast cancer patients monitored for years in new safety trial
Disease control ENROLLING_BY_INVITATIONTOL2506A (OVELIA) is a Phase 3, single arm, open-label study evaluating the effectiveness of TOL2506 in suppressing ovarian function in premenopausal women with HR+, HER2-negative breast cancer and men with HR+ breast cancer. The TOL2506A-EXT study described here is a safety exte…
Phase: PHASE3 • Sponsor: Tolmar Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Gene therapy for hemophilia: how safe is it years later?
Knowledge-focused Recruiting nowA study to learn about the long-term safety and efficacy of giroctocogene fitelparvovec or fidanacogene elaparvovec in patients with hemophilia A or hemophilia B respectively, who have received treatment through prior participation in a Pfizer-sponsored clinical trial. Data colle…
Phase: PHASE3 • Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Robots vs. surgeons: can a machine improve knee replacement outcomes?
Disease control OngoingTo determine if robotically-assisted UKA results in more consistent and improved component positioning and better patient reported outcome scores compared to manual TKA and MAKO TKA.
Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Bypass without surgery: new scope procedure helps cancer patients eat again
Symptom relief CompletedA prospective, multi-center, single-arm study for unresectable malignant gastric outlet obstruction with EUS-guided double-balloon-occluded gastrojejunostomy bypass (EPASS)
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Virtual programs tested to save alaska native youth from suicide
Knowledge-focused CompletedTwo interventions will be delivered virtually to American Indian/Alaska Native youth who have been hospitalized with suicidal attempt, suicidal ideation, or associated risk behaviors, including alcohol-related injury.
Phase: NA • Sponsor: RAND • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Should all healthy newborns get their DNA screened? study investigates
Knowledge-focused CompletedThis research study is exploring the use of genomic sequencing in the newborn period to screen healthy babies for current and future health risks. The study will enroll a diverse cohort of 500 healthy infants and their parents from Boston, MA; New York City, NY; and Birmingham, A…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
New scan could predict which brain tumors will shrink
Diagnosis Recruiting nowThis clinical trial examines an investigational scan (64Cu-DOTA-trastuzumab positron emission tomography \[PET\]/magnetic resonance imaging \[MRI\]) in imaging patients with HER2+ breast cancer that has spread to the brain (brain metastasis). Diagnostic procedures, such as 64Cu-D…
Phase: PHASE4 • Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
New heart pump aims to make risky artery procedures safer
Disease control ENROLLING_BY_INVITATIONThe Impella ECP Study is a prospective, multi-center, single-arm study evaluating the rate of major adverse cardiovascular and cerebrovascular events (MACCE) with the Impella ECP device in adult patients undergoing elective or urgent high-risk percutaneous coronary intervention. …
Phase: NA • Sponsor: Abiomed Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New hope for schizophrenia: study tests switching to SEP-363856
Disease control CompletedThis study evaluated how well SEP-363856 works and how safe it is in people with schizophrenia that switch to SEP-363856 from their current antipsychotic medication.
Phase: PHASE3 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New infusion drug hopes to tame rare hormone disorder
Disease control Recruiting nowThis trial will evaluate the effects of different doses of Lu AG13909 in adult participants with congenital adrenal hyperplasia, also called CAH. CAH is a rare genetic disorder that affects a person's ability to produce certain hormones. The main goals of this trial are to learn …
Phase: PHASE1, PHASE2 • Sponsor: H. Lundbeck A/S • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Zolgensma's long-term effects under the microscope in new 5-year study
Disease control OngoingThis is a global, prospective, multi-center study that is designed to assess the long-term safety and efficacy of OAV101 in patients who participated in an OAV101 clinical trial. The assessments of safety and efficacy in Study COAV101A12308 will continue for 5 years after enrollm…
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Ulcerative colitis drug study halted early
Disease control TerminatedThe purpose of this study is to explore the safety, efficacy, effects on quality of life (QOL), and biomarker response of ozanimod in participants with moderate to severely active ulcerative colitis (UC) in clinical practice.
Phase: PHASE4 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New ALS drug QRL-201 enters human safety testing
Disease control OngoingThe primary objective of this study is to determine the safety and tolerability of multiple doses of QRL-201 in people living with ALS
Phase: PHASE1 • Sponsor: QurAlis Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New stent aims to seal brain aneurysms safely
Disease control Recruiting nowTo analyse the clinical safety and efficacy of the DERIVO® 2heal® Embolisation Device in the standard clinical routine of flow diversion treatment with respect to the mid- and long-term clinical and angiographic outcomes.
Sponsor: Acandis GmbH • Aim: Disease control
Last updated Jun 26, 2026 14:18 UTC
-
New MRI scan could reveal Cancer's true aggressiveness
Diagnosis Recruiting nowThis is a single center prospective imaging study investigating the utility of hyperpolarized 13C-pyruvate +/-13C,15N-Urea/ metabolic MR imaging. The current protocol will serve as a companion imaging biomarker study paired with standard of care (SOC) therapeutics, as well as inv…
Phase: PHASE1, PHASE2 • Sponsor: Robert Bok, MD, PhD • Aim: Diagnosis
Last updated Jun 27, 2026 12:37 UTC